Taken together, these studies indicated that deletion of trp53 tumor suppressor in the biliary lineage combined with chemical damage inflicted specifically to the biliary system resulted in iCCA with a cholangiocyte serving as a CoO. The gene discussed is TP53; the disease is neoplasm.